Gallery | Kids take flight at camp for children with asthma or diabetes – Myrtle Beach Sun News

Gallery | Kids take flight at camp for children with asthma or diabetes
Myrtle Beach Sun News
Children play and even fly in Camp Air Waves & Seven Seas at Terry & Don's Gymnastics Fun & Fitness Center. The camp is for children with asthma or diabetes sponsored by Grand Strand Health. It includes education on their condition, field trips and crafts.

and more »

View full post on asthma – Google News

Teva Announces FDA Acceptance of Reslizumab For Asthma – Lung Disease News


Lung Disease News

Teva Announces FDA Acceptance of Reslizumab For Asthma
Lung Disease News
Reslizumab is being developed as treatment of inadequately controlled asthma in adults and young people who have increased blood eosinophils, despite being under treatment with an inhaled corticosteroid (ICS) drug regimen. “Despite currently available …
FDA to review Teva asthma biologicBioPharma Dive
FDA will review Teva's asthma biologic reslizumabPharmaTimes
Stock Update (NYSE:TEVA): Teva Pharmaceuticals Industries Ltd (ADR Smarter Analyst
PMLiVE
all 20 news articles »

View full post on asthma – Google News

Unsafe asthma prescribing ‘must end’ – BBC News


BBC News

Unsafe asthma prescribing 'must end'
BBC News
Tens of thousands of people with asthma in the UK are not getting the right medicines to keep their condition safely under control, according to an audit. The charity Asthma UK, which analysed nearly 100,000 patient records to reach this estimate, says
Thousands of asthma-sufferers at risk of potentially life-threatening attacks Mirror.co.uk
Asthma inhaler prescription warningKidderminster Shuttle

all 10 news articles »

View full post on asthma – Google News

FDA Committee Recommends Approval Of Nucala For Adult Asthma Patients – Lung Disease News


Lung Disease News

FDA Committee Recommends Approval Of Nucala For Adult Asthma Patients
Lung Disease News
An FDA advisory committee recently voted unanimously to approve Nucala for the treatment of severe asthma with eosinophilic inflammation in patients 18 and older. The committee, however, decided against the use of the therapy in adolescents aged …
GSK's new asthma biologic gains FDA panel backingPMLiVE

all 2 news articles »

View full post on asthma – Google News